Inovio Pharmaceuticals, Inc. (INO) has a MoatMap StockRank of 0/100 based on Quality (13/100), Value (34/100), and Momentum (18/100) factor scores. The current signal is STRONG SELL. Inovio Pharmaceuticals, Inc., a US-based biotech company, operates in a highly speculative sector with no direct macro tailwind from the identified themes. Biotech companies rarely meet the fund's criteria for asset-light, quality compounders with durable moats due to long development cycles, regulatory hurdles, and high capital burn. The 'STRONG_SELL' signal confirms severe underlying fundamental issues.